Abeona Therapeutics is a biotechnology company focused on developing innovative gene and cell therapies for the treatment of rare diseases and genetic disorders
The company is dedicated to advancing its proprietary platform technologies to create targeted therapies that can address the underlying causes of these conditions. Through its research and development efforts, Abeona aims to bring transformative treatments to patients, leveraging its expertise in gene delivery and cell-based therapies to provide hope for those suffering from debilitating illnesses.
Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
